The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy

Cited 9 time in webofscience Cited 0 time in scopus
  • Hit : 259
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorKim, Jaehoko
dc.contributor.authorLee, Heung Kyuko
dc.date.accessioned2021-06-21T06:50:07Z-
dc.date.available2021-06-21T06:50:07Z-
dc.date.created2021-06-21-
dc.date.created2021-06-21-
dc.date.created2021-06-21-
dc.date.issued2021-05-
dc.identifier.citationMOLECULES AND CELLS, v.44, no.5, pp.356 - 362-
dc.identifier.issn1016-8478-
dc.identifier.urihttp://hdl.handle.net/10203/286020-
dc.description.abstractAn increasing number of studies have revealed an interaction between gut microbiota and tumors. The enrichment of specific bacteria strains in the intestines has been found to modulate tumor growth and influence the mechanisms of tumor treatment. Various bacteria are involved in modulating the effects of chemotherapeutic drugs currently used to treat patients with cancer, and they affect not only gastrointestinal tract tumors but also distant organ tumors. In addition, changes in the gut microbiota are known to be involved in the antitumor immune response as well as the modulation of the intestinal immune system. As a result, the gut microbiota plays an important role in modulating the efficacy of immune checkpoint inhibitors. Therefore, gut microbiota could be considered as an adjuvant treatment option with other cancer treatment or as another marker for predicting treatment response. In this review, we examine how gut microbiota affects cancer treatments.-
dc.languageEnglish-
dc.publisherKOREAN SOC MOLECULAR & CELLULAR BIOLOGY-
dc.titleThe Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy-
dc.typeArticle-
dc.identifier.wosid000655676800010-
dc.identifier.scopusid2-s2.0-85107084904-
dc.type.rimsART-
dc.citation.volume44-
dc.citation.issue5-
dc.citation.beginningpage356-
dc.citation.endingpage362-
dc.citation.publicationnameMOLECULES AND CELLS-
dc.identifier.doi10.14348/molcells.2021.0032-
dc.identifier.kciidART002718419-
dc.contributor.localauthorLee, Heung Kyu-
dc.description.isOpenAccessY-
dc.type.journalArticleReview-
dc.subject.keywordAuthorcancer-
dc.subject.keywordAuthorcancer therapy-
dc.subject.keywordAuthorgut microbiota-
dc.subject.keywordAuthorimmune checkpoint inhibitors-
dc.subject.keywordPlusFUSOBACTERIUM-NUCLEATUM-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusPROMOTES-
dc.subject.keywordPlusIMMUNOTHERAPY-
dc.subject.keywordPlusMETABOLITES-
dc.subject.keywordPlusRESISTANCE-
dc.subject.keywordPlusDYSBIOSIS-
dc.subject.keywordPlusBACTERIA-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordPlusCELLS-
Appears in Collection
MSE-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 9 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0